144 related articles for article (PubMed ID: 21859840)
1. A novel kinase inhibitor of FADD phosphorylation chemosensitizes through the inhibition of NF-κB.
Schinske KA; Nyati S; Khan AP; Williams TM; Johnson TD; Ross BD; Tomás RP; Rehemtulla A
Mol Cancer Ther; 2011 Oct; 10(10):1807-17. PubMed ID: 21859840
[TBL] [Abstract][Full Text] [Related]
2. High-throughput molecular imaging for the identification of FADD kinase inhibitors.
Khan AP; Schinske KA; Nyati S; Bhojani MS; Ross BD; Rehemtulla A
J Biomol Screen; 2010 Oct; 15(9):1063-70. PubMed ID: 20855560
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas.
Chen G; Bhojani MS; Heaford AC; Chang DC; Laxman B; Thomas DG; Griffin LB; Yu J; Coppola JM; Giordano TJ; Lin L; Adams D; Orringer MB; Ross BD; Beer DG; Rehemtulla A
Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12507-12. PubMed ID: 16109772
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death.
Uwagawa T; Li Z; Chang Z; Xia Q; Peng B; Sclabas GM; Ishiyama S; Hung MC; Evans DB; Abbruzzese JL; Chiao PJ
Cancer; 2007 May; 109(10):2142-53. PubMed ID: 17410536
[TBL] [Abstract][Full Text] [Related]
5. Metallothionein 2A an interactive protein linking phosphorylated FADD to NF-κB pathway leads to colorectal cancer formation.
Marikar FM; Jin G; Sheng W; Ma D; Hua Z
Chin Clin Oncol; 2016 Dec; 5(6):76. PubMed ID: 28061540
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD).
Wajant H; Haas E; Schwenzer R; Muhlenbeck F; Kreuz S; Schubert G; Grell M; Smith C; Scheurich P
J Biol Chem; 2000 Aug; 275(32):24357-66. PubMed ID: 10823821
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin sensitizes cancer cells to Smac mimetic via synergistic activation of the CYLD/RIPK1/FADD/caspase-8-dependent apoptosis.
Yang C; Ran Q; Zhou Y; Liu S; Zhao C; Yu X; Zhu F; Ji Y; Du Q; Yang T; Zhang W; He S
Apoptosis; 2020 Jun; 25(5-6):441-455. PubMed ID: 32418059
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel blocker of I kappa B alpha kinase that enhances cellular apoptosis and inhibits cellular invasion through suppression of NF-kappa B-regulated gene products.
Ichikawa H; Takada Y; Murakami A; Aggarwal BB
J Immunol; 2005 Jun; 174(11):7383-92. PubMed ID: 15905586
[TBL] [Abstract][Full Text] [Related]
9. Fas-associated death-domain protein inhibits TNF-alpha mediated NF-kappaB activation in cardiomyocytes.
Chao W; Shen Y; Li L; Zhao H; Meiler SE; Cook SA; Rosenzweig A
Am J Physiol Heart Circ Physiol; 2005 Nov; 289(5):H2073-80. PubMed ID: 15980038
[TBL] [Abstract][Full Text] [Related]
10. Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer.
Singh S; Shi Q; Bailey ST; Palczewski MJ; Pardee AB; Iglehart JD; Biswas DK
Mol Cancer Ther; 2007 Jul; 6(7):1973-82. PubMed ID: 17620428
[TBL] [Abstract][Full Text] [Related]
11. Ebselen sensitizes glioblastoma cells to Tumor Necrosis Factor (TNFalpha)-induced apoptosis through two distinct pathways involving NF-kappaB downregulation and Fas-mediated formation of death inducing signaling complex.
Sharma V; Tewari R; Sk UH; Joseph C; Sen E
Int J Cancer; 2008 Nov; 123(9):2204-12. PubMed ID: 18709644
[TBL] [Abstract][Full Text] [Related]
12. FADD and the NF-kappaB family member Bcl-3 regulate complementary pathways to control T-cell survival and proliferation.
Rangelova S; Kirschnek S; Strasser A; Häcker G
Immunology; 2008 Dec; 125(4):549-57. PubMed ID: 18557791
[TBL] [Abstract][Full Text] [Related]
13. The adaptor protein FADD and the initiator caspase-8 mediate activation of NF-κB by TRAIL.
Grunert M; Gottschalk K; Kapahnke J; Gündisch S; Kieser A; Jeremias I
Cell Death Dis; 2012 Oct; 3(10):e414. PubMed ID: 23096115
[TBL] [Abstract][Full Text] [Related]
14. The Fas-associated death domain protein suppresses activation of NF-kappa B by LPS and IL-1 beta.
Bannerman DD; Tupper JC; Kelly JD; Winn RK; Harlan JM
J Clin Invest; 2002 Feb; 109(3):419-25. PubMed ID: 11828002
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of sunitinib as single agent or in combination with chemotherapy in nasopharyngeal carcinoma.
Hui EP; Lui VW; Wong CS; Ma BB; Lau CP; Cheung CS; Ho K; Cheng SH; Ng MH; Chan AT
Invest New Drugs; 2011 Dec; 29(6):1123-31. PubMed ID: 20467883
[TBL] [Abstract][Full Text] [Related]
16. Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB.
Ou D; Wang X; Metzger DL; Robbins M; Huang J; Jobin C; Chantler JK; James RF; Pozzilli P; Tingle AJ
Hum Immunol; 2005 Jul; 66(7):799-809. PubMed ID: 16112027
[TBL] [Abstract][Full Text] [Related]
17. Opioid receptor agonists enhance the phosphorylation state of Fas-associated death domain (FADD) protein in the rat brain: functional interactions with casein kinase Ialpha, Galpha(i) proteins, and ERK1/2 signaling.
García-Fuster MJ; Ramos-Miguel A; Miralles A; García-Sevilla JA
Neuropharmacology; 2008 Oct; 55(5):886-99. PubMed ID: 18657552
[TBL] [Abstract][Full Text] [Related]
18. Oncrasin targets the JNK-NF-κB axis to sensitize glioma cells to TNFα-induced apoptosis.
Gupta P; Dixit D; Sen E
Carcinogenesis; 2013 Feb; 34(2):388-96. PubMed ID: 23125226
[TBL] [Abstract][Full Text] [Related]
19. Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition.
Cusack JC; Liu R; Houston M; Abendroth K; Elliott PJ; Adams J; Baldwin AS
Cancer Res; 2001 May; 61(9):3535-40. PubMed ID: 11325813
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of FADD by the kinase CK1α promotes KRASG12D-induced lung cancer.
Bowman BM; Sebolt KA; Hoff BA; Boes JL; Daniels DL; Heist KA; Galbán CJ; Patel RM; Zhang J; Beer DG; Ross BD; Rehemtulla A; Galbán S
Sci Signal; 2015 Jan; 8(361):ra9. PubMed ID: 25628462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
